In conclusion, our experimental data demonstrate that the cytotoxic conjugate formed by the anti HER2 affibody and monomethyl auristatin E efficiently interacts with HER2-expressing cancer cells in vitro, allowing for a selective and specific delivery of the cytotoxic payload. Here, ERBB2 is linked to cancer.